U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
154831154831Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic RhinitisCompletedNo Results AvailableAllergic RhinitisDrug: Cetirizine dihydrochloride (10 mg/ml) liposomal formulation|Drug: Cetirizine dihydrochloride (10 mg/ml) buffer solution|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00533637
154832154832Myfortic vs. Cellcept in Kidney Transplant RecipientsCompletedNo Results AvailableEnd Stage Renal DiseaseDrug: Mycophenolate Sodium Delayed Release Tablets|Drug: Mycophenolate Mofetilhttps://ClinicalTrials.gov/show/NCT00533624
154833154833Effect of MK0524A on Flushing Caused by Niacin (0524A-056)CompletedNo Results AvailableFlushingDrug: MK0524A, /Duration of Treatment : 4 Weeks|Drug: Comparator : niacin /Duration of Treatment : 1 Weekshttps://ClinicalTrials.gov/show/NCT00533611
154834154834A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)CompletedNo Results AvailableObesityDrug: MK0557https://ClinicalTrials.gov/show/NCT00533598
154835154835BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNo Results AvailableLung CancerDrug: BAY 43-9006|Drug: Paclitaxel|Drug: Carboplatin|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00533585
154836154836Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene TransferTerminatedNo Results AvailableEpidermolysis Bullosa Dystrophicahttps://ClinicalTrials.gov/show/NCT00533572
154837154837Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of BuphenylCompletedNo Results AvailableDiabetes|Insulin ResistanceDrug: sodium phenylbutyrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00533559
154838154838Activated Protein C in Acute Stroke TrialTerminatedNo Results AvailableStrokeDrug: Activated Protein Chttps://ClinicalTrials.gov/show/NCT00533546
154839154839A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNo Results AvailableGastric CancerDrug: docetaxel, oxaliplatinhttps://ClinicalTrials.gov/show/NCT00533533
154840154840Evaluation of Dosing Interval of Higher Doses of RanibizumabCompletedNo Results AvailableMacular Degeneration|Choroidal NeovascularizationDrug: ranibizumabhttps://ClinicalTrials.gov/show/NCT00533520
154841154841Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of AgeCompletedHas ResultsPneumococcal Disease|Streptococcus Pneumoniae VaccinesBiological: Synflorix|Biological: Infanrix hexa|Biological: Rotarixhttps://ClinicalTrials.gov/show/NCT00533507
154842154842The Effect of Patients' Participation in Improving Diabetes CareCompletedNo Results AvailableType 2 Diabetes MellitusBehavioral: physician feedback (A)https://ClinicalTrials.gov/show/NCT00533494
154843154843Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)CompletedNo Results AvailableObesityDrug: MK0557https://ClinicalTrials.gov/show/NCT00533481
154844154844"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."CompletedNo Results AvailablePainDrug: Lidocaine Cream 4%https://ClinicalTrials.gov/show/NCT00533468
154845154845Gabapentin for the Treatment of Neuroleptic-Induced TremorTerminatedNo Results AvailableNeuroleptic-Induced TremorDrug: Gabapentinhttps://ClinicalTrials.gov/show/NCT00533455
154846154846Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas RecipientsActive, not recruitingNo Results AvailableType 1 DiabetesDrug: Rapamycin|Drug: Tacrolimus and mycophenolate mofetil|Drug: Rapamune and Tacrolimus|Drug: Mycophenolate Mofetilhttps://ClinicalTrials.gov/show/NCT00533442
154847154847Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyCompletedNo Results AvailableNon-small Cell Lung CancerDrug: enzastaurin|Drug: pemetrexed|Drug: carboplatin|Drug: bevacizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00533429
154848154848Safety of ON 01910.Na in Patients With MyelodysplasiaCompletedNo Results AvailableMyelodysplastic Syndrome (MDS)Drug: ON 01910 Nahttps://ClinicalTrials.gov/show/NCT00533416
154849154849MK0686 in Postsurgery Dental Pain (0686-002)CompletedNo Results AvailablePain, PostoperativeDrug: MK0686https://ClinicalTrials.gov/show/NCT00533403
154850154850Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mgTerminatedNo Results AvailableTuberculosis|HIV InfectionsDrug: efavirenzhttps://ClinicalTrials.gov/show/NCT00533390
154851154851ACTiF- Assessment of Closed Tibial FracturesCompletedNo Results AvailableTibial FracturesDrug: CP-533, 536|Drug: Placebo|Procedure: Standard of Care|Drug: CP-533,536|Drug: CP-533,536|Drug: CP-533,536https://ClinicalTrials.gov/show/NCT00533377
154852154852Effect of SBG in Patients With Breast CancerCompletedNo Results AvailableBreast CancerDrug: SBG (Soluble beta-glucan)https://ClinicalTrials.gov/show/NCT00533364
154853154853Safety and Efficacy of AGN201781 in Neuropathic PainTerminatedHas ResultsNeuralgiaDrug: AGN201781|Drug: placebohttps://ClinicalTrials.gov/show/NCT00533351
154854154854Weight Gain Prevention for Breast Cancer SurvivorsActive, not recruitingNo Results AvailableBreast CancerBehavioral: Weight Gain Prevention Program|Behavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00533338
154855154855MK0524A Clinical Efficacy StudyCompletedNo Results AvailableHypercholesterolemiaDrug: Comparator : placebo (unspecified) / Duraton of Treatment: 4 Weeks|Drug: MK0524A, niacin (+) laropiprant / Duration of Treatment : 4 Weeks|Drug: Comparator : niacin / Duraton of Treatment: 4 Weekshttps://ClinicalTrials.gov/show/NCT00533312
154856154856Hydralazine Valproate for Ovarian CancerRecruitingNo Results AvailableOvarian CancerDrug: Hydralazine and magnesium valproate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00533299
154857154857Do Benzodiazepines Improve the Outcome of Mechanical Physiotherapy for Lumbar Disk ProlapseCompletedNo Results AvailablePain|Disability|ParesisDrug: benzodiacepinehttps://ClinicalTrials.gov/show/NCT00533286
154858154858Non-US Study of AA4500 (XIAFLEXâ„¢, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedHas ResultsAdvanced Dupuytren's DiseaseBiological: collagenase clostridium histolyticumhttps://ClinicalTrials.gov/show/NCT00533273
154859154859A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)CompletedNo Results AvailableBipolar Disorder|Schizophreniahttps://ClinicalTrials.gov/show/NCT00533260
154860154860Arthroplasty Inflammation Prophylaxis With CelecoxibNot yet recruitingNo Results AvailablePostoperative PainDrug: Celecoxibhttps://ClinicalTrials.gov/show/NCT00533247

* Görseller ve İçerik tekif hakkına sahip olabilir